BINEX Co., Ltd. announces an Equity Buyback for 283,286 shares.
August 22, 2021
Share
BINEX Co., Ltd. (KOSDAQ:A053030) announces a share repurchase program. Under the program, the company will repurchase up to 283,286 shares. The purpose of the program is to improve shareholder value and stabilize stock prices. The program will expire on November 23, 2021. As of August 22, 2021, the company had 553,226 shares in treasury within the scope available for dividend and had 0 share in treasury through other repurchases.
BINEX.CO.LTD is a Korea-based company mainly engaged in the manufacturing and distribution of pharmaceuticals. The Companyâs products include digestive system agents, circulatory system agents, ulcer agents, antacids, anti-inflammatory agents, analgesics, gastrointestinal (GI) tract regulators and antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, as well as ointment, creams and others. It also manufactures bio medicines and raw materials. The Company distributes its products within domestic market and to overseas markets.
BINEX CO., LTD. 
